Health Headline: New oral vaccine strategy could help combat colorectal cancer

A research team investigating the use of the bacterium Listeria monocytogenes against colorectal cancer has discovered a way to build a modified version of Listeria as an oral vaccine to prime the immune system directly within the gut, where anti-tumor cells are then generated.

Top Stories

01:32

Keyport residents raise health concerns amid possible cancer cluster

02:35

Spring sings once again tomorrow as temperatures warm up

01:41

DEA seizes stockpile of fentanyl and meth in Passaic County

NJ reports first measles case of 2026

01:54

NJ businesses hopeful to receive tariff refunds

00:37

Body pulled from Hackensack River identified as missing Weehawken man

02:02

NJ studio puts local spin on ‘Tiny Desk’ with ‘Tiny Shelf’ sessions

00:37

Jersey Proud: High school softball rivalry rewards kids with critical illnesses